Untapped Potential? Representativeness in Pragmatic Clinical Trials

Caleigh Propes; Kayla Mehl; Stephanie R Morain

doi:10.1001/jama.2024.22983

Untapped Potential? Representativeness in Pragmatic Clinical Trials

JAMA. 2024 Nov 20. doi: 10.1001/jama.2024.22983. Online ahead of print.

Authors

Caleigh Propes^{1

2}, Kayla Mehl¹, Stephanie R Morain^{1

2}

Affiliations

¹ Johns Hopkins Berman Institute of Bioethics, Baltimore, Maryland.
² Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

PMID: 39565629
DOI: 10.1001/jama.2024.22983

No abstract available

Plain language summary

This JAMA Viewpoint explores the potential of pragmatic clinical trials to improve demographic representativeness and health equity in clinical research.